Cargando…
Preparation of Ganglioside GM1 by Supercritical CO(2) Extraction and Immobilized Sialidase
Monosialotetrahexosylganglioside (GM1) has good activity on brain diseases and was developed to be a drug applied in clinics for neurological disorders and nerve injury. It is difficult to isolate GM1 in industry scale from the brains directly. In this work, a simple and highly efficient method with...
Autores principales: | Ji, Li, Qiao, Zhonghui, Zhang, Xin, Cheng, Xiaolei, Wang, Weiyang, Zhang, Fan, Zhou, Yifa, Yuan, Ye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832980/ https://www.ncbi.nlm.nih.gov/pubmed/31623198 http://dx.doi.org/10.3390/molecules24203732 |
Ejemplares similares
-
Sialidase NEU3 action on GM1 ganglioside is neuroprotective in GM1 gangliosidosis
por: Allende, Maria L., et al.
Publicado: (2023) -
Intraventricular Sialidase Administration Enhances GM1 Ganglioside Expression and Is Partially Neuroprotective in a Mouse Model of Parkinson’s Disease
por: Schneider, Jay S., et al.
Publicado: (2015) -
Pathophysiology of Ganglioside GM1 in Ischemic Stroke: Ganglioside GM1: A Critical Review
por: Zhang, Wenchao, et al.
Publicado: (2019) -
Ecto-ganglioside-sialidase activity of herpes simplex virus-transformed hamster embryo fibroblasts
Publicado: (1976) -
Physiopathological function of hematoside (GM3 ganglioside)
por: INOKUCHI, Jin-ichi
Publicado: (2011)